Athira pharma reports first quarter 2025 financial results and pipeline and business updates

Completed healthy volunteer phase 1 clinical study of ath-1105 as a potential treatment for amyotrophic lateral sclerosis (als); full healthy volunteer data expected in 2h25
ATHA Ratings Summary
ATHA Quant Ranking